Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John B. Rhodes currently holds 23,470 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John B. Rhodes has been a net buyer of TNXP stock. They have purchased $120.0K and sold $0 worth of shares.
John B. Rhodes's most recent insider trade was on Jun 1, 2018, when they purchased 7,500 shares at $3.33 per share.
John B. Rhodes serves as Executive at Tonix Pharmaceuticals Holding Corp. (TNXP). They have executed 9 insider transactions totaling $120.0K over their tenure at the company.
John B. Rhodes holds the position of Executive at Tonix Pharmaceuticals Holding Corp., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
John B. Rhodes has shown a buying trading pattern, with $120.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John B. Rhodes was on Apr 26, 2013, when they sold $66.7K worth of TNXP shares. This transaction involved 166,667 shares at $0.40 per share.
John B. Rhodes currently owns 23,470 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John B. Rhodes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John B. Rhodes has 9 Form 4 filings on record as an insider at Tonix Pharmaceuticals Holding Corp..
Set alerts for John B. Rhodes and 40,000+ other insiders.